Osmotic release oral system methylphenidate versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in Chinese youth: 8-week comparative …

Y Su, L Yang, MA Stein, Q Cao… - Journal of Child and …, 2016 - liebertpub.com
Objective: The purpose of this study was to compare the short-term efficacy, tolerability, and
1-year adherence in Chinese children and adolescents with attention-deficit/hyperactivity …

An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in …

SSF Gau, HY Shen, WT Soong… - Journal of Child & …, 2006 - liebertpub.com
This study examined the efficacy and safety of osmotic release oral system methylphenidate
(OROS MPH) as compared with immediate-release MPH (IR MPH) in children with attention …

Remission in children and adolescents diagnosed with attention-deficit/hyperactivity disorder via an effective and tolerable titration scheme for osmotic release oral …

WJ Chou, SJ Chen, YS Chen, HY Liang… - Journal of Child and …, 2012 - liebertpub.com
Objectives: The purpose of this study was to identify the optimal dose of osmotic release oral
system methylphenidate (OROS-MPH) using a dosage forced-titration scheme to achieve …

Osmotic release oral system methylphenidate is more effective than immediate release methylphenidate: a retrospective chart review in Turkish children with attention …

UA Ardic, ES Ercan, E Ercan, D Yuce… - … Bülteni-Bulletin of …, 2014 - Taylor & Francis
Objective: The aim of this study was to evaluate the efficacy and safety of osmotic release
oral system methylphenidate (OROS-MPH) compared with immediate release …

Efficacy and tolerability of osmotic release oral system-methylphenidate in children with attention-deficit hyperactivity disorder according to comorbid psychiatric …

HJ Yoon, KH Yook, DI Jon, JH Seok… - Journal of the Korean …, 2008 - koreascience.kr
Objectives: The purpose of this study was to evaluate the efficacy and tolerability of osmotic
release oral system-methylphenidate (OROS-MPH) in children with attention-deficit …

An open-label, self-control, prospective study on cognitive function, academic performance, and tolerability of osmotic-release oral system methylphenidate in children …

Y Zheng, JM Liang, HY Gao, ZW Yang, FJ Jia… - Chinese Medical …, 2015 - mednexus.org
Background: Attention-deficit hyperactivity disorder (ADHD) is the most common mental and
behavioral disorder in school-aged children. This study evaluated the effect of osmotic …

A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of osmotic-controlled release oral delivery system …

N Takahashi, T Koh, Y Tominaga, Y Saito… - The World Journal of …, 2014 - Taylor & Francis
Objectives. To evaluate the safety and efficacy of osmotic-controlled release oral delivery
system (OROS) methylphenidate (MPH) HCl in adults with attention-deficit/hyperactivity …

Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder

Y Zheng, Y Wang, Q Jiong, L Wang, L Zou… - Chinese Medical …, 2011 - journals.lww.com
Background Attention deficit hyperactivity disorder (ADHD) is one of the most common
mental disorders during childhood, characterized by the core symptoms of hyperactivity …

An open-label, randomized trial of methylphenidate and atomoxetine treatment in children with attention-deficit/hyperactivity disorder

CY Shang, YL Pan, HY Lin, LW Huang… - Journal of Child and …, 2015 - liebertpub.com
Objective: The efficacy of both methylphenidate and atomoxetine has been established in
placebo-controlled trials. The present study aimed to directly compare the efficacy of …

Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children

XX Pan, HW Ma, B Wan, XM Dai - Zhongguo Dang dai er ke za zhi …, 2008 - europepmc.org
Objective Methylphenidate is recommended as a first-line modality for treating attention
deficit hyperactivity disorder (ADHD). In the past, immediate release methylphenidate (IR …